Biomarker Discordances and Alterations Observed in Breast Cancer Treated with Neoadjuvant Chemotherapy: Causes, Frequencies, and Clinical Significances.

Yilmaz, Cengiz; Cavdar, Demet Kocatepe

Yilmaz, Cengiz; Cavdar, Demet Kocatepe.

Afiliación

Yilmaz C; Department of Medical Oncology, Bozyaka Training and Research Hospital, The University of Health Sciences, Izmir 35170, Turkey.
Cavdar DK; Department of Pathology, Bozyaka Training and Research Hospital, The University of Health Sciences, Izmir 35170, Turkey.

Curr Oncol ; 29(12): 9695-9710, 2022 12 08.

Article en En | MEDLINE | ID: mdl-36547175

Asunto(s)

Biomarcadores de Tumor; Neoplasias de la Mama; Terapia Neoadyuvante; Femenino; Humanos; Biomarcadores de Tumor/metabolismo; Neoplasias de la Mama/diagnóstico; Neoplasias de la Mama/terapia; Relevancia Clínica; Antígeno Ki-67/metabolismo; Neoplasia Residual; Receptor ErbB-2/metabolismo; Receptores de Estrógenos/metabolismo; Receptores de Progesterona/metabolismo; Estudios Retrospectivos; Clasificación del Tumor

Palabras clave

biomarker alteration; biomarker discordance; breast cancer; chemosensitivity; neoadjuvant chemotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Biomarcadores de Tumor / Terapia Neoadyuvante Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Curr Oncol Año: 2022 Tipo del documento: Article País de afiliación: Turquía

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google